Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Columbus, Ohio

Phase 1 cancer trials in Columbus, OH

86 Phase 1 cancer studies are recruiting participants at sites in Columbus as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Columbus at a glance

  • 86 studies are recruiting at a site in Columbus.
  • By phase: Early Phase 1 (4), Phase 1 (39), Phase 1/2 (43).
  • By sponsor: industry (54), university, hospital or other (25), government (7).
  • By research area: Lymphoma (33), Breast Cancer (20), Lung Cancer (20), Prostate Cancer (6), Pancreatic Cancer (4), Melanoma (3).
  • Most recent update to one of these records: November 17, 2026.

Breast cancer studies recruiting in Columbus

Basic details from each study's public record (the 30 most recently updated of 86). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Ohio State University Comprehensive Cancer Center
    Registry record
    NCT05422794 · updated
  2. A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

    • Phase 1
    • Ages 18 to 55
    • Female participants
    Sponsor
    TerSera Therapeutics LLC
    Study site
    The Mark H. Zangmeister Center-Mid Ohio Oncology/Hematology, Inc.
    Registry record
    NCT07310420 · updated
  3. A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    The Ohio State University Comprehensive Cancer Center
    Registry record
    NCT03424005 · updated
  4. Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Genmab
    Study site
    Ohio State University Comprehensive Cancer Center (OSUCCC)- The James Cancer Hospital and Solove Research Institute
    Registry record
    NCT05579366 · updated
  5. A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    The Ohio State University (OSU) Wexner Medical Center
    Registry record
    NCT06400472 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Columbus, OH on ClinicalTrials.gov.

Lung cancer studies recruiting in Columbus

  1. Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Ohio State University Comprehensive Cancer Center
    Registry record
    NCT06287775 · updated
  2. Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    SystImmune Inc.
    Study site
    Ohio State University
    Registry record
    NCT07080242 · updated
  3. Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    The Jame Outpatient Care West Campus
    Registry record
    NCT07397338 · updated
  4. FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Gilead Sciences
    Study site
    Ohio State University CRS
    Registry record
    NCT06303505 · updated
  5. KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0015)
    Registry record
    NCT04165070 · updated
  6. Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Synthekine
    Study site
    The James Cancer Hospital and Solove Research Institute
    Registry record
    NCT05098132 · updated
  7. Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Study site
    The Mark H Zangmeister Center /ID# 272502
    Registry record
    NCT06772623 · updated
  8. Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Tango Therapeutics, Inc.
    Study site
    Ohio State University Comprehensive Cancer Center
    Registry record
    NCT06810544 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Columbus, OH on ClinicalTrials.gov.

Prostate cancer studies recruiting in Columbus

  1. A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Regeneron Pharmaceuticals
    Study site
    James Cancer Hospital and Solove Research Institute
    Registry record
    NCT03972657 · updated
  2. Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

    • Phase 1
    • Ages 18 to 100
    • Male participants
    Sponsor
    Janux Therapeutics
    Study site
    The Ohio State University
    Registry record
    NCT05519449 · updated
  3. A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    K36 Therapeutics, Inc.
    Study site
    The Ohio State University Comprehensive Cancer Center
    Registry record
    NCT07103018 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Columbus, OH on ClinicalTrials.gov.

Lymphoma studies recruiting in Columbus

  1. The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

    • Phase 1/2
    • Up to age 22
    • All sexes
    Sponsor
    PedAL BCU, LLC
    Study site
    Nationwide Children's Hospital
    Registry record
    NCT04726241 · updated
  2. Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    John Reneau
    Study site
    Ohio State University Comprehensive Cancer Center
    Registry record
    NCT04848064 · updated
  3. Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Ohio State University Comprehensive Cancer Center
    Registry record
    NCT04301076 · updated
  4. A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

    • Phase 1/2
    • Ages 12 and older
    • All sexes
    Sponsor
    Nuvalent Inc.
    Study site
    OSU Brain & Spine Hospital
    Registry record
    NCT05384626 · updated
  5. A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    The James Cancer Hospital and Solove Research Institute
    Registry record
    NCT05091424 · updated
  6. A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    The Ohio State University (OSU)
    Registry record
    NCT07226843 · updated
  7. Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Veronika Bachanova
    Study site
    Ohio State University Comprehensive Cancer Center
    Registry record
    NCT03681561 · updated
  8. A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

    • Early Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    AIDS Malignancy Consortium
    Study site
    The Ohio State University
    Registry record
    NCT04139304 · updated
  9. A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    AstraZeneca
    Registry record
    NCT06564038 · updated
  10. Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

    • Phase 1/2
    • Ages 13 to 90
    • All sexes
    Sponsor
    Vironexis Biotherapeutics Inc.
    Study site
    The Ohio State University Wexner Medical Center
    Registry record
    NCT06533579 · updated
  11. Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Ohio State University Comprehensive Cancer Center
    Registry record
    NCT06860594 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Columbus, OH on ClinicalTrials.gov.

Pancreatic cancer studies recruiting in Columbus

  1. Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Ohio State University Comprehensive Cancer Center
    Registry record
    NCT05372614 · updated
  2. Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    RayzeBio, Inc.
    Registry record
    NCT07165132 · updated
  3. Lead-212 PSV359 Therapy for Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 to 90
    • All sexes
    Sponsor
    Perspective Therapeutics
    Study site
    Ohio State University
    Registry record
    NCT06710756 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Columbus, OH on ClinicalTrials.gov.

Ask about studies near Columbus

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Ohio

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call